Pharsight

CELLVAX patents facing oppositions

Top patents of CELLVAX facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3152234B1 08 Jul, 2020 Antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory t lymphocytes Jun, 2035 1